A 2023 survey from the American Heart Association conducted by The Harris Poll, found that a majority (70%) of heart attack and stroke survivors are unaware that LDL cholesterol is commonly referred to as ‘bad cholesterol.’
Leveragen and Moderna enter partnership to advance therapeutics
Leveragen will use the platform to create several binding modules against therapeutic targets chosen by Moderna. Credit: MIND AND I / Shutterstock. Leveragen and Moderna